Table 1.
Multivariate analysis for the identified prognostic genes for overall survival (OS).
Variables | P-value | HR | 95% CI-low | CI-high |
---|---|---|---|---|
Overall survival | ||||
LEF1 (scenario 8) | 0.00642 | 1.58 | 1.14 | 2.19 |
CEBPAdmα | 0.00214 | 0.33 | 0.16 | 0.67 |
FLT3ITD β | 0.00025 | 1.77 | 1.30 | 2.40 |
NPM1+β | 0.00005 | 0.51 | 0.37 | 0.71 |
WBC countδ, × 109/L | 0.00886 | 1.00 | 1.00 | 1.00 |
Age$ | 0.00005 | 1.02 | 1.01 | 1.03 |
Overall survival | ||||
SFRP2 (scenario 2, 8) | 0.00091 | 2.00 | 1.33 | 3.00 |
CEBPAdmα | 0.00160 | 0.32 | 0.16 | 0.65 |
FLT3ITD β | 0.00007 | 1.87 | 1.37 | 2.55 |
NPM1+ β | 0.00006 | 0.52 | 0.38 | 0.71 |
WBC countδ, × 109/L | 0.00470 | 1.00 | 1.00 | 1.01 |
Age$ | 0.00007 | 1.02 | 1.01 | 1.03 |
Overall survival | ||||
RUNX1 (scenario 3) | 0.03768 | 1.38 | 1.02 | 1.88 |
CEBPAdmα | 0.00308 | 0.34 | 0.17 | 0.69 |
FLT3ITD β | 0.00023 | 1.78 | 1.31 | 2.41 |
NPM1+ β | 0.00004 | 0.51 | 0.37 | 0.71 |
WBC countδ, × 109/L | 0.01106 | 1.00 | 1.00 | 1.00 |
Age$ | 0.00001 | 1.02 | 1.01 | 1.03 |
Overall survival | ||||
PSMD2 (scenario 5, 6) | 0.00220 | 0.60 | 0.43 | 0.83 |
CEBPAdmα | 0.00130 | 0.31 | 0.15 | 0.63 |
FLT3ITD β | 0.00006 | 1.87 | 1.38 | 2.55 |
NPM1+ β | 0.00160 | 0.59 | 0.42 | 0.82 |
WBC countδ, × 109/L | 0.00270 | 1.00 | 1.00 | 1.01 |
Age$ | 0.00009 | 1.02 | 1.01 | 1.03 |
Overall survival | ||||
XPNPEP (scenario 1) | 0.00200 | 1.56 | 1.18 | 2.07 |
CEBPAdmα | 0.00084 | 0.30 | 0.15 | 0.60 |
FLT3ITD β | 0.00130 | 1.66 | 1.22 | 2.26 |
NPM1+ β | 0.00020 | 0.55 | 0.40 | 0.75 |
WBC countδ, × 109/L | 0.01190 | 1.00 | 1.00 | 1.00 |
Age$ | 0.00015 | 1.02 | 1.01 | 1.03 |
Overall survival | ||||
PPARD (scenario 4, 6) | 0.00063 | 0.52 | 0.36 | 0.76 |
CEBPAdmα | 0.00075 | 0.29 | 0.14 | 0.60 |
FLT3ITD β | 0.00011 | 1.83 | 1.35 | 2.48 |
NPM1+ β | 0.00084 | 0.57 | 0.41 | 0.79 |
WBC countδ, × 109/L | 0.00360 | 1.00 | 1.00 | 1.01 |
Age$ | 0.00001 | 1.02 | 1.01 | 1.03 |
Overall survival | ||||
AXIN2 (scenario 8) | 0.0038 | 1.79 | 1.21 | 2.66 |
CEBPAdmα | 0.0009 | 0.30 | 0.15 | 0.61 |
FLT3ITD β | 0.0003 | 1.77 | 1.30 | 2.40 |
NPM1+ β | 0.0003 | 0.55 | 0.40 | 0.76 |
WBC countδ, × 109/L | 0.0100 | 1.00 | 1.00 | 1.00 |
Age$ | 0.00004 | 1.02 | 1.01 | 1.03 |
Cox proportional hazard model for multivariable analyses of prognostic markers for overall survival. Analyses included 344 AML patients. Abbreviations: HR, hazard ratio; CI, confidence interval; α CEBPAdouble−mutation status versus CEBPAwt, β FLT3ITD versus no FLT3ITD mutation, β NPM1mutant versus NPM1wt, δ WBC count higher than 20 × 109/L versus lower than 20 × 109/L, $ Age is used as continuous variable.